Consent of Independent Registered Public Accounting Firm
We consent to the inclusion in this Registration Statement on Form S-1 (File number yet to be assigned) of our audit report dated June 29, 2023, with respect to the consolidated balance sheets of Nascent Biotech Inc. as of March 31, 2023 and 2022, and the related consolidated statements of operations, stockholders’ equity (deficit), and cash flows for the two years then ended, appearing in the Annual Report on Form 10-K for the year ended March 31, 2023. Our report dated June 29, 2023, relating to aforementioned financial statements, includes a going concern paragraph relating to substantial doubt of the Company's ability to continue as a going concern.
We also consent to the references to us under the heading “Experts” within the Registration Statement.
Fruci & Associates II, PLLC
March 9, 2024
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.
